Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytotoxic chemotherapy refers to a group of drugs used primarily in cancer therapy that work by directly killing rapidly dividing cells, mainly by interfering with cellular processes such as DNA replication, mitosis, and protein synthesis. These agents include alkylating agents, antimetabolites, topoisomerase inhibitors, and microtubule inhibitors, each with a range of specific molecular targets but united by the end effect of inducing cell death through direct cytotoxic mechanisms. In addition to their direct effects, cytotoxic chemotherapies can modulate the immune system, sometimes enhancing anti-tumor immune responses but also causing broad immunosuppression. While effective in a range of malignancies, they are associated with significant toxicity due to effects on normal proliferating cells.
DNA damage (alkylation/crosslinking, e.g., cyclophosphamide, cisplatin); Inhibition of DNA synthesis (antimetabolites, e.g., 5-FU, methotrexate); Disruption of mitosis (microtubule inhibitors, e.g., paclitaxel, vincristine); Topoisomerase inhibition (e.g., doxorubicin, etoposide); Induction of apoptosis; Immunomodulation (induction of immunogenic cell death and effects on immune cell populations)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytotoxic chemotherapy (null).